ORKA
The table below shows Oruka Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $46.94M | $61.58M | $37.43M | $42.45M | $53.36M | $49.07M |
| Short-term investments | $290.11M | $314.07M | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $343.86M |
| $376.87M |
| $37.59M |
| $42.70M |
| $54.42M |
| $49.97M |
| Property, plant & equipment | $288.00K | $162.00K | $10.00K | $25.00K | $48.00K | $21.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $488.62M | $396.02M | $37.86M | $43.09M | $54.92M | $50.43M |
| Accounts payable | - | - | $362.00K | $334.00K | $1.12M | $1.77M |
| Total current liabilities | $15.37M | $13.04M | $637.00K | $1.13M | $3.50M | $3.50M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $16.69M | $13.80M | $841.00K | $1.41M | $3.88M | $3.91M |
| Retained earnings | -$189.16M | -$83.72M | -$188.74M | -$183.40M | -$173.48M | -$154.15M |
| Total equity | $471.93M | $382.22M | $37.02M | $41.67M | $51.04M | $46.52M |